Reaction
Otitis Media Acute reporting signals
As of the last recalculation, Otitis Media Acute appears in 727 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is MERCAPTOPURINE (PRR 44.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Mercaptopurine | 26 | 44.5 | 44.5 |
| Sirolimus | 16 | 34.7 | 34.8 |
| Pegaspargase | 14 | 33.4 | 33.4 |
| Palivizumab | 15 | 28.5 | 28.5 |
| Polyethylene Glycol | 9 | 24.1 | 24.1 |
| Ketoconazole Foam | 12 | 23.6 | 23.6 |
| Ketoconazole Cream, 2% | 12 | 23.5 | 23.5 |
| Valproate Sodium | 16 | 22.6 | 22.7 |
| Vincristine Sulfate | 21 | 21.1 | 21.1 |
| Clobazam | 14 | 16.7 | 16.7 |
| Botulinum Toxin Type A | 7 | 16.3 | 16.3 |
| Lumacaftor And Ivacaftor | 4 | 13.4 | 13.4 |
| Canakinumab | 5 | 13.3 | 13.3 |
| Loratadine And Pseudoephedrine Sulfate | 3 | 10.8 | 10.8 |